Funding for this research was provided by:
Sci-Tech Project Foundation of Guangzhou City (201803010003)
Received: 18 October 2020
Accepted: 12 April 2021
First Online: 20 April 2021
: The study with human clinical samples was approved by the Shanghai Outdo Biotech Company institutional review board (Approval Number: YB M-05-02) and the Sun Yat-Sen University Cancer Center institutional review board (approval number: SZR2020-145). All animal studies were carried out according to the National Institute of Health Guide for the Care and Use of Laboratory Animals with the approval of Sun Yat-Sen University Cancer Center Institutional Animal Care and Use Committee (Approval Number: L102022020000V).
: All authors reviewed and approved the final version for submission.
: The authors declare no competing financial interests.